|07-12-2018 02:20 PM CET - Health & Medicine||
Synthetic Biology Market Size, Trends, Demand, Growth, Opportunities and Key Manufacturers Forecast to 2025
Press release from: The Insight Partners
The Insight Partners added “Synthetic Biology Market – Global Trends, 2018 Analysis and 2025 Forecasts” report to its research database. The Report is spread across 150 Pages and Supported by 10 Company Leaders.
Global Synthetic Biology Market Report 2018-2025 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The report firstly introduced the Synthetic Biology basics: definitions, classifications, applications and market overview, product specifications, manufacturing processes, cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. Global Synthetic Biology Market competition by top manufacturers with production, price, revenue (value) and market share for each manufacturers.
Download PDF Brochure at bit.ly/2Ji5L6H
The List of Companies:
1. Thermo Fisher Scientific Inc.
2. Merck KGaA
4. Agilent Technologies
7. Integrated DNA Technologies, Inc.
8. Twist Bioscience
9. New England Biolabs
10. Synthetic Genomics Inc.
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the synthetic biology market.
-Highlights key business priorities in order to assist companies to realign their business strategies.
-The key findings and recommendations highlight crucial progressive industry trends in the global synthetic biology market, thereby allowing players across the value chain to develop effective long-term strategies.
-Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
-Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
-Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Synthetic biology, an interdisciplinary branch of biology and engineering, involves designing and constructing new devices, systems and biological parts as well as re-designing existing, natural biological systems. It has various application in the field of food & agriculture, medicine, and other areas. Technologies such as, gene synthesis, genome engineering and cloning and sequencing help the researchers to understand organization of natural biological systems and design new biological entities offering various advantages to humans.
In our study, we have segmented the synthetic biology market by product, technology and application. On the basis of product, the market is segmented into enzymes, oligonucleotides, chassis organisms and xeno-nucleic acids. Enzymes acquired the largest market among the products due to its wide range of applications in healthcare. On the basis of technology, the market is segmented into gene synthesis, genome engineering, measurement and modeling, cloning and sequencing, nanotechnology, and others. Gene synthesis has the largest market share among the technologies due to an increasing research and development activities in genetics and growing number of market players offering products and solutions for gene synthesis. On the basis of application, global synthetic biology market is segmented into industrial applications, food and agriculture, medical applications, environmental applications, and others. Geographically, the market for synthetic biology is segmented into North America, Europe, Asia Pacific (APC), Middle East and Africa (MEA) and South and Central America (S&CAM).
For More Information at bit.ly/2NLHWbc
The synthetic biology market is estimated to grow at a CAGR of 28.2% during the forecast period from 2018 to 2025. The market for synthetic biology is estimated to reach US$ 56,044.9 Mn in 2025. The market for synthetic biology is witnessing a potential growth rate during the previous years and is expected to witness similar trend in the coming years. Global synthetic biology market is driven by extensive use of enzymes kits and other gene synthesis products in research institutes and academics. Additionally, rising demand for enzyme based kits and solutions required for gene manipulation and rising awareness about genetic engineering among the healthcare professionals in developed nations also accelerate the market growth. However, competition among existing market players may restrain the growth of the market.
In North America, the market is driven by an increasing investment by government organizations and institutes such as Department of Energy, the National Science Foundation (NSF), Department Of Defense (DoD), the National Institutes of Health (NIH), and the US Department of Agriculture (USDA). While, Asia Pacific is the fastest growing market driven increasing investment by private sector companies such as Evolva Biotech Pvt. Ltd and increasing demand for synthetic biology technologies of industrial and medical applications.
The major players operating in the market of synthetic biology market include ThermoFisher Scientific Inc., Merck KGaA, Novozymes, Agilent Technologies, Amyris, GenScript, Integrated DNA Technologies, Inc., Twist Bioscience, New England Biolabs, Synthetic Genomics Inc. and others.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
This release was published on openPR.
News-ID: 1123008 • Views: 231More releases